<- Go Home

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.

Market Cap

$510.1M

Volume

999.4K

Cash and Equivalents

$616.2M

EBITDA

-$477.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$176.4M

Profit Margin

80.94%

52 Week High

$75.20

52 Week Low

$5.26

Dividend

N/A

Price / Book Value

0.64

Price / Earnings

-0.75

Price / Tangible Book Value

0.71

Enterprise Value

$339.5M

Enterprise Value / EBITDA

-0.86

Operating Income

-$538.6M

Return on Equity

63.51%

Return on Assets

-19.19

Cash and Short Term Investments

$616.2M

Debt

$445.6M

Equity

$797.9M

Revenue

$218.0M

Unlevered FCF

-$195.7M

Sector

Chemicals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches